Member Info for TGoodland

Nope, there is a place for both PCR and POC testing, lots of room for both players, i have some spare capital from a BOO trade so was doing some research, i was interested in AVCT until I spat my coffee out when i saw you had a £355m Market cap?

Can you please help in what would justify that mcap? Getting a saliva POC test would be great but it won't put you at a £1bn market cap that is nonsenical.

Overconfidence is the reason most people lose money on AIM, and the fact i'm questioning your investments and you're getting offended, that shows overconfidence and think you should be receptive to a differing opinion, it might save you money.

Revenues of £5.5m in 2019 before covid and now it's a £355m Market Cap????? LOL that is ABSURD have i read that wrong?

What am i missing here? Revenue for 2020 likely to be £3m Year to date, cash burn in the multiple millions? How can that market cap be justified.

If we can get significant demand for the ELISA, then boy we are in for a ride!!

£1.60 per test PROFIT which could lead to £166.4m a year Revenue and £83.2m Margin.....

That's not even including the other 6 parts of the business !!

Maybe so! It’s a long term core holding in my portfolio alongside some global equity funds & I’d be happy with £2 next year but won’t complain if it’s sooner !!

Well done all. Just shows that you need to trust your research, ignore the noise and be patient.

Post the placing The share was toxic but we are being rewarded for our patience and research. Onwards and upwards and £2 this time next year once we make the most of the Covid opportunity and take a dominant market share in HIV and Food intolerance.

Nice to be back at these levels. - What worries me is that i don't want the market putting too much value on the Govt order.

If they only order 10m to do a large scale statistical programme it wont matter to us as there are lots of strings to our bow, i'm most excited about the ELISA tests being sold as they are £1.60 a test profit as opposed to 75p.

Hopefully we can arrange the contract so we can sell these UK RTC tests on Amazon for £10 a pop!

Anticlimax not anti body! ;)

Is that Mologic had to go through a process to get selected by us. The Elisa and LFT test will be the big opportunity here, the UK RTC is just an extra nice to have.

They must have serious data that shows the demand for these products in the Mid-low income countries that Colin referred to. We're undergoing validation in 18 countries (up from 15 in the RNS).

The margins are high on Mologic tests and if we can get the Saliva Lateral flow test by December as he said then we are sitting very pretty as a company.

The RTC will sell x number of tests to the government and if they can sort the contract out to sell to other countries (thinking USA mainly) then there is less 'social responsibility' there and we will be charging a higher price.

Nice to see a blue day to get back to where we was, lets hope for some approvals and orders through soon to get this party started properly

It’s not just a Covid stock that’s why ;)

Even if we just do the antibody, HIV and Food I’m sure we’ll be in the £’s ! Love it

Nice one. If we got an Antigen LFT then that is exactly what Han**** is after when he mentioned about community testing.

Everyone is on the Avacta train but they have failed to deliver anything so far and as the kings of LFT I’d expect us to smash it.

So much more positive after today. Delighted for Colin as I’m sure the share price and Investor feedback would have been playing on his mind. Let’s hope he gets it right and makes us all rich and earns a nice early retirement with his family !

So discounting the Antigen, Food Intolerence and HIV tests.........

UK RTC

200k a week, £1.50 revenue, 75p profit.

200k x 1.50 = 350k (Times by 52 =. £18.2m revenue £9.1m profit)

Mologic LFT

800k a week £3.20 revenue, £1.60 profit

800k x 3.20 = 2.56m a week (times by 52 is 133m a year revenue and 61.5m profit

Mologic Elisa Test

1m a week, £1.50 revenue 75p profit

1.5m a week revenue and 750k a week profit.

X 52 = 78m revenue and 39m profit.

£229.2m Revenue and £115m Profit from 52 weeks worth of Covid sales at full capacity.

That is serious money and a great margin. Does anyone know anything about the Mologic LFT? This is the biggest piece of the pie for us at the moment. Let’s hope the orders come flying In

Would love an insight into how many units we’ve sold.

22.5m last month... surely we’re not sending them out at £2.25 a Pop

https://www.biorxiv.org/content/10.1101/2020.03.13.990226v1

Market should be pricing in an extension of our contract with PHE.

Matt Han****:
"Testing will be big enough to cope with the figures in the Royal College report even with the current testing technology. If there is a breakthrough where we can get a testing technology that's even easier to roll out where it can be done at the bedside or in the community rather than having to be sent to a lab then we will have a bigger roll out"

The figures Han**** is refering to is 360,000 tests a day. We will have a big piece of that, and those that will be using other standards of test, i.e less accurate, we will likely be used as the 'second check'

It’s clearly wrong as well as we have 2m capacity in a WEEK!!!!!

Are we just going to sell half a weeks production and then pack up for the year ?!??

Honestly... bunch of idiots. Worse PR in the world

Fair play GGGG. Top stuff!

Anything I’ve missed? Fingers crossed for a nice blue week

LOL you was a ‘MMs playing games’ awaybfrom a full set of Aim bingo!